Skip to main content

China

RealClear Context

Click below to continue reading this story, discover more China stories from over 25 years of RealClear archives, or follow this topic to stay in the know.

Muhammad Shoaib • RealClearDefense

China’s Revised Mobilization Law

China’s revised National Defense Mobilization Law (中华人民共和国国防动员法), which took effect on October 1, 2026, marks a significant development in China’s...

8h agoRead it on RealClearDefense
5,220 stories
8h ago
Defense

China’s Revised Mobilization Law and the Expanding Reach of National Defense

Muhammad Shoaib • RealClearDefense • November 20, 2026

China’s revised National Defense Mobilization Law (中华人民共和国国防动员法), which took effect on October 1, 2026, marks a significant development in China’s strategy of managing its national security and preparing for war. The substantially expanded 2026 law, which replaces the 2010 legislation, establishes a more comprehensive framework for organizing and coordinating China’s economic, technological, and human resources for national defense mobilization. Containing 82 articles across 14 chapters, the law provides an institutional mechanism for China to facilitate a rapid transition between peacetime and wartime conditions, converting economic and social resources into national defense capabilities.

4d ago
Awais Feroze Hanif • The Diplomat

China’s Drone Carrier Swarms Ahead

Beijing is at the forefront of developing drone carriers as combat platforms, especially compared to the United States. But will that translate into...

4d agoRead it on The Diplomat
4d ago
Max Colchester • The Wall Street Journal

Behind the Nvidia Affair Sits a Vast Chinese Spying Machine

Beijing is deploying the world’s biggest intelligence-gathering operation to bolster its tech industry. U.S. officials worry Jensen Huang was...

4d agoRead it on The Wall Street Journal
1w ago
John West • The Strategist (ASPI)

China’s Epic Campaign To Steal America’s Secrets

China’s efforts, both legal and illegal, to acquire America’s intellectual property (IP) have long been a central theme in the U.S.–China...

1w agoRead it on The Strategist (ASPI)
1w ago
Defense

China’s Epic Campaign To Steal America’s Secrets

John West • RealClearDefense • November 11, 2026

China’s efforts, both legal and illegal, to acquire America’s intellectual property (IP) have long been a central theme in the U.S.–China relationship. A new book, The Great Heist: China’s Epic Campaign to Steal America’s Secrets, by David R Shedd and Andrew Badger, both formerly of the U.S. Defense Intelligence Agency, offers a welcome and up-to-date forensic analysis of the issue.

The authors cite the FBI estimate of IP theft (mainly by China) which has cost the U.S. economy up to U.S. $600 billion (A$860 billion) a year over the past decade. Industrial espionage has been a driving catalyst for the rise of China, even if other factors have also played a role. According to some estimates China may already have a technological edge against the United States. ASPI’s Critical Technology Tracker estimates that China now publishes the most high-impact research in 69 of the 74 technologies tracked, with the U.S. leading in the remaining five.

1w ago
Gabriel Dominguez • South China Morning Post

Is the PLA Rehearsing To Keep U.S. Forces Out of a Taiwan Conflict?

More than 100 vessels have been reported in the western Pacific and South China Sea but no large-scale drill has been announced...

1w agoRead it on South China Morning Post
1w ago
Rob Maness • RealClearDefense

America Must Win the Biotech Race Against China

The United States has spent decades building military capabilities designed to deter conflict and respond to crises. But military power alone cannot...

1w agoRead it on RealClearDefense
1w ago
Defense

America Must Win the Biotech Race Against China

Rob Maness • RealClearDefense • November 10, 2026

For years, American leaders have warned about the dangers of depending on China for products that are critical to our economy and national security. Semiconductors, rare earth minerals, telecommunications equipment, and energy technologies have all received well-deserved scrutiny. The medicines and biotechnology that underpin public health deserve the same attention, and the competition in that field is moving faster than many policymakers realize.

Today, China occupies a central position in the global pharmaceutical supply chain, particularly with regards to the key starting materials used to manufacture many essential medicines. Hundreds of drugs approved for use in the United States rely on at least one chemical produced solely in China, in part because Beijing has heavily subsidized its chemical and drug-ingredient producers, allowing them to sell at prices competitors elsewhere struggle to match. This creates a vulnerability that impacts not just healthcare but also our national security.

1w ago
Fuyang Yu • The Diplomat

How China’s Naval-Air Reach Is Offsetting the Malacca Dilemma

China remains exposed to maritime disruption, but its expanding regional reach is increasing the military and political costs of exploiting that...

1w agoRead it on The Diplomat